Madrid

• Trial of Cannabidiol for the treatment of alcohol dependence Not authorised
  2023-504439-42-00 4 alcohol dependence
• Trial of Cannabidiol for the treatment of alcohol dependence Not authorised
  2023-504439-42-01 4 alcohol dependence
• HARMONi-3 Not authorised
  2023-504989-37-00 5 Metastatic Squamous Non-small Cell Lung Cancer
• Dose expansion, safety and efficacy study of intravesical instillation of TARA-002 in adults with high-grade non-muscle invasive bladder can … Not authorised
  2023-505062-28-00 9 Non-muscle invasive bladder cancer
• Investigating a New Treatment: Clinical Study on Coenzyme Q (Ubiquinol) for Patients with Mitochondrial Disorders and Cerebellar Ataxias Not authorised
  2023-505244-18-01 4 Mitochondrial disorders and/or cerebellar ataxias
• Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh … Not authorised
  2023-505311-20-00 5 Metastatic Non-Small Cell Lung Cancer
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno … Not authorised
  2023-506014-47-00 9 Resected (R0 or R1) pancreatic ductal adenocarcinoma
• A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCER Not authorised
  2023-508058-24-00 1 LOCALLY ADVANCED OR METASTATIC LOW TUMOR VOLUME COLORECTAL CANCER
• Evaluation of the safety and efficacy of the drug AL8326 in the post-first treatment of small cell lung cancer. Not authorised
  2023-509067-24-00 4 Small Cell Lung Cancer (SCLC) patients who need ≥2nd line treatment wi
• A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescent … Not authorised
  2023-509723-41-00 3 Refractory/ relapsed acute lymphoblastic leukemia in children, adolesc
• "A Clinical Study to Evaluate the Effectiveness of Beltavac® with polymerized extract of grass pollen mixture in allergic rhinoconjunctivit … Not authorised
  2023-510033-28-00 4 allergic rhinoconjunctivitis caused due to exposure to pollen grasses
• TRAP study: Testosterone for Androgen Receptor Polymorphism. Not authorised
  2024-510596-37-00 6 low ovarian reserve according to Bologna criteria and carriers of andr
• A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti … Not authorised
  2024-512369-14-00 4 Non-small cell lung cancer (NSCLC).
• A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr … Not authorised
  2024-512403-39-00 1 Advanced Solid Tumors Who Are Beyond Standard of Care
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• EORTC 2237-BCG-QLG: Improvement of Quality of Life through supportive treatments for Endocrine Therapy – related symptoms in patients with e … Not authorised
  2024-513442-10-00 5 ER positive HER2 negative breast cancer stages I-II
• Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Not authorised
  2024-514827-40-00 9 Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
• A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralaser … Not authorised
  2024-516611-24-00 3 Advanced solid tumour
• A study to investigate WEF-001 in patients with Advanced KRAS-Mutant Solid Tumours. Not authorised
  2024-518644-21-00 9 Advanced KRAS- Mutant Solid Tumours
• A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Not authorised
  2024-519745-30-00 9 Immune Thrombocytopenia (ITP)
• "A Clinical Study to Evaluate the Effectiveness of Beltavac® with polymerized extract of grass pollen mixture in allergic rhinoconjunctivit … Not authorised
  2025-520581-22-00 4 Allergic rhinoconjunctivitis caused due to exposure to pollen grasses
• A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po … Not authorised
  2025-521052-35-00 7 Patients with HER2Positive Advanced Breast Cancer
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 5 Schizophrenia
• PHASE I/IIa CLINICAL TRIAL FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE WITH A NEW GENERATION OF MESENCHYMAL STROMAL CELLS ECTOPICALLY EXP … Not authorised
  2025-523139-21-00 9 Patients who have developed acute GVHD refractory to corticosteroids a

Showing 25–48 of 3,550 trials